1. CONCLUSION: Pharmacokinetics of CFR and TMR are similar.

2. The pharmacokinetics of IDEBENONE have not been extensively studied.

3. Objective To study the pharmacokinetics of netilmicin in rabbits.

4. Formulate the distribution of photosensitizer in vessels by pharmacokinetics.

5. OBJECTIVE: To compare the in vivo pharmacokinetics of gatifloxacin between normal canis familiaris and hepatic injury model group.

6. Objective To investigate the pharmacokinetics of clindamycin phosphate vagina gel in healthy Chinese female volunteers.

7. OBJECTIVE: Pharmacokinetics and bioavailability of domestic and imported moclobemide tablets after single - dose oral administration.

8. In this study, the pharmacokinetics of Oleuropein in rabbits were evaluated.

9. Objecdive To study pharmacokinetics and relative bioavailability of cefathiamidine and cefathiamidine salt in rabbit intramuscularly .

10. OBJECTIVE To study the pharmacokinetics of omeprazole ( OME ) in 8 patients with liver cirrhosis.

11. The pharmacokinetics of piracetam in rats is of the linear pharmacokinetic characteristic.

12. The structure - activity relationship, pharmacology , pharmacokinetics, clinical efficacy , ADRs, and drug interaction of mirtazapine antidepressant, are reviewed.

13. Pharmacokinetics, toxicological functions, drug residue, withdrawal time and the application perspective are summarized in this article.

14. Objective : To study the pharmacokinetics and bioavailability of cefalexin capsule.

15. The presented method can be used for the pharmacokinetics study of netilmicin in rat serum, and can be a new choice for the determination of aminoglycoside antibiotics in biological samples.

16. Conclusions: The changes of the pharmacokinetics were influenced not only by liver function and kidney function, acid-base balance, but also by sleep closed.

17. To study pharmacokinetics and availability of national - apramycin sulfate by oral and intravenous administration in 5 pigs.

18. Sustained release tablets(SRT)of labetalol and the human pharmacokinetics were studied.

19. OBJECTIVE : To study chiral pharmacokinetics process of amlodipine enantiomers of rabbits in vivo.

20. AIM To study the pharmacokinetics and bioavailability of clinafloxacin in rats.

21. Results: The mimesis accuracy of Grey pharmacokinetics model was higher than that of traditional ones.

22. Objective To study the pharmacokinetics and bioavailability of apigenin solid lipid nanoparticles after peroral administration in rats.

23. Objective To study the pharmacokinetics of cyclosporin A (CsA) with or without combination of berberine hydrochloride (Ber) in renal transplantation recipients.

24. Objective:To compare the pharmacokinetics, clinical characteristic and ratio of effective price of desflurane with isoflurane in closed circuit anesthesia.

25. OBJECTIVE To study the pharmacokinetics and bioequivalent of the domestic and imported cephradine injection in healthy volunteers.

26. The synthesis, physico-chemical properties, research on dosage forms, analysis, pharmacokinetics, mechanisms, clinical uses and new development in uses of disulfiram were reviewed.

27. AIM To develop a HPLC-UV method for determinating the concentration of zopiclone in human plasma and to compare the pharmacokinetics of zopiclone tablets of domestic vs imported.

28. Professor Saltzman starts the lecture with an introduction to pharmacokinetics and pharmacodynamics.

29. OBJECTIVE To develop an HPLC-MS/MS method for the determination of cyclobenzaprine in human plasma and study pharmacokinetics in healthy volunteers.

30. OBJECTIVE To prepare Gliclazide bioadhesive sustained release tablets and investigate the in vitro release characteristics,(Sentence dictionary) adhesion in the ex vivo tissues and the pharmacokinetics in beagle dogs.

31. CONCLUSION: The RP-HPLC method is sensitive, accurate simple and suitable for determination of the concentration of clonazepam in serum and for the clinical pharmacokinetics research.

32. RESULTS: Unreasonable drug use is the main cause of serous adverse drug event, except from pharmacokinetics.

33. AIM : To study the bioequivalence and pharmacokinetics of doxycycline enteric - coated microsomes capsules and doxycycline tablets.

34. Objective:To determine the pharmacokinetics and relative availability of domestic cefaclor.

35. OBJECTIVE:To study the pharmacokinetics of a single dose of intramuscularly injected ziprasidone mesylate in healthy volunteers.

36. It has been used in evaluating the relative bioavailability of ticlopidine tablet and its pharmacokinetics.

37. Objective To study the change of pharmacokinetics parameters of imipenem in the interstitial fluids under eschar of burn rabbits in the early stage.

38. This paper introduced the pharmacodynamics , pharmacokinetics, the clinical efficacy and safety of mildronate.

39. The disappearing-degradation of fenvalerate in paddy soils could be expressed by one compartmental uptake model of pharmacokinetics.

40. OBJECTIVE: To study the pharmacokinetics of cyclosporin A (CsA) with or without combination of berberine chloride(Ber)in renal transplanted recipients.

41. OBJECTIVE To determine prazosin hydrochloride in human plasma by HPLC-MS method, and to investigate its pharmacokinetics and bioequivalance.

42. Li Huande, Professor, Doctoral supervisor. Specializes in clinical evaluation of drug, in vivo (intoxicant) pharmaceutical analysis and clinical pharmacokinetics.

43. The pharmacokinetics of the total effective constituents extraction in Carassius auratus was studied by drug cumulative method.

44. CONCLUSION The administration route is the key factor which influences the pharmacokinetics of brucine in vivo.

45. Objective To study pharmacokinetics and relative bioavailability of enalapril maleate tablets in healthy volunteers.

46. Achymthes bidentata Blume decoction can increase concentrations of clindamycin in cardia, hepar, lung and kidney; can influence pharmacokinetics parameters of clindamycin in rabbits.

47. Recent progress in mechanism, bioactivities, pharmacokinetics, safety and clinical efficacy of hydroxocobalamin is briefly reviewed in this paper.

48. CONCLUSION The method is sensitive and accurate for the determination of busulfan concentration in human plasma. It is suitable for the pharmacokinetics study of busulfan.

49. Objective To investigate the effects of Szechwan Lovage Phizome combined with different proportions of Turmeric Root Tuber on the pharmacokinetics of ferulic acid(FA)in rabbits.

50. The main tasks for post-doctoral fellow include research in pharmacokinetics and clinical pharmacology, especially in drug metabolism, pharmacokinetics,() and pharmacogenetics .

51. Objective: To study pharmacokinetics of desflurane, isoflurane and halothane by membrane oxygenator in vitro.

52. Objective To study the effects of acute normovolemic hemodilution on the pharmacokinetics of high dose fentanyl undergoing open heart surgery.

53. Aim To determine scutellarin in dog plasma and study the pharmacokinetics of scutellarin in the dog.

54. Objective : To study the pharmacokinetics and bioavailability of danshensu in rat.

55. Biological sample analytical methods are the basis of pharmacokinetics research.

56. Dr. Edward Young HEPARIN: Biochemistry, Mechanism of Action, Pharmacokinetics and Limitations.

57. AIM:To observe the pharmacokinetics and adverse drug reaction (ADR) after high dose cytarabine maintenanced chemotherapy in 5 children with acute nonlymphocytic leukemia (ANLL).

58. AIM : To study pharmacokinetics of lorazepam injection in healthy ese volunteers.

59. The text has carried on detailed analysis to Pharmacokinetics and neuropharmacology of Ganfukang dropping pill .

60. Objective To study the pharmacokinetics and bioequivalence of lorazepam tablets in Chinese healthy volunteers.

61. Objective:To observe the changes of fentanyl pharmacokinetics in rats during anhepatic phase by treatment of large dose of dexamethasone and to investigate the extrahepatic metabolism of fentanyl.

62. Aim:To develop a high performance liquid chromatographic (HPLC)with electrochemical detection method for the determination of scutellarin in rat plasma and to study its pharmacokinetics in rats.

63. OBJECTIVE:To study the pharmacokinetics and bioavailability of cefalexin dispersible tablet in healthy male volunteers.

64. Pharmacokinetics ( PK ) and pharmacodynamics ( PD ) are two important parts of pharmacology.

65. OBJECTIVE To establish a LC-MS/MS method for the simultaneous determination of guaifenesin, bromhexine, ambroxol in human plasma and to study their pharmacokinetics in healthy volunteers.

66. OBJECTIVE:To study the pharmacokinetics and relative bioavailability of ibuprofen sustained release capsules in healthy volunteers for evaluating the bioequi valency .

67. Conclusions Meclofenoxate, another component in the powder injection of piracetam and meclofenoxate, does not influence the pharmacokinetics of piracetam, the major component.

68. AIM : To study pharmacokinetics and bioavailability of chlorpheniramine maleate tablets in young healthy volunteers.

69. CONCLUSION The method applied for determination of gentiopicrin content in blood was simple, accurate and feasible for the study of gentiopicrin pharmacokinetics in rats.

70. Objective: To study the pharmacokinetics of cefradine capsules and establish a HPLC method for determining the contents of the cefradine in human plasma.

71. The pharmacokinetics of Isoxicam solution in rabbits and rats was investigated.

72. Objective To study the human pharmacokinetics and bioequivalence of erythromycin ethylsuccinate suspension.

73. Multidrug resistance-associated protein(MRP) plays an important role in the pharmacokinetics of a drug in the body. However, the function of MRP can be affected by probenecid.

74. To study the pharmacokinetics and relative bioavailability of tosufloxacin tosylate dispersible tablet in healthy volunteers.

75. OBJECTIVE To establish a HPLC-ECD method for determining scutellarin in rat plasma and to study pharmacokinetics of scutellarein in rats.

76. AIM: To study the pharmacokinetics and relative bioavailability of propylthiouracil tablet in Chinese healthy male volunteers.

77. AIM:To study the pharmacokinetics and bioequivalence of spironolactone in Chinese healthy people.

78. Conclusion CYP2C9 genetic polymorphism has a significant influence on the pharmacokinetics of tolbutamide. Pharmacogenomic study will be helpful in guiding rational and individualized medication.

79. Aim To investigate the effect of ketoconazole on the metabolism in vitro and pharmacokinetics of saquinavir.

80. HPLC method was established for the determination of scutellarin in rat plasma, and pharmacokinetics after ig administration of Yinshanlian granules were investigated.

81. OBJECTIVE To study pharmacokinetics and Bioequivalence of domperidone chewable tablets in healthy Chinese volunteers.

82. AIM : To compare pharmacokinetics and bioavailability of Naproxen Sodium Tablets with imported in 20 healthy male volunteers .

83. The article describes its pharmacokinetics, the mechanism of action, and clinical trials as an anti - depressant.

84. These results suggested that the multiple-peak phenomenon of PIX pharmacokinetics was caused by enterohepatic circulation (EHC).

85. Objective: Pharmacokinetics of FPA PVP coprecipitate was studied in order to provide reference for clinical use.

86. Conclusion Pharmacokinetics study on target of toxic components with cross-reaction of periplocoside is feasible through drug monitor system of digoxin immunoreaction.

87. AIM To study the pharmaceutical characterization and pharmacokinetics of long circulating liposomes containing daunorubicin.

88. OBJECTIVE:To determine the pharmacokinetics and relative bioavailablityof triprolidine hydrochloride capsules and tab1ets.

89. Methocarbamol is a useful adjunct in improving patient recovery. In this article, we summarized its pharmacokinetics, synthesis, pharmacological effect,(http:///pharmacokinetics.html) clinical use and safety.

90. The effect of florfenicol(FFC) on the activity of cytochrome P450 2E1 in Carassius auratus was evaluated by pharmacokinetics using chlorzoxazone(CZX) as a specific substrate.

91. The pharmacokinetics and bioavailability of acyclovir ( ACV ) were studied in 10 hepatitis B surface antigen carriers.

92. Objective To study the distribution and pharmacokinetics of Gd andGd - DTPA in mice.

93. The effect of traditional Chinese medicine and its preparation on pharmacokinetics of cyclosporin is reviewed in this paper.

94. Conclusions The method is proved to be accurate, simple, and suitable for the preclinical pharmacokinetics scutellarin in dogs.

95. What drugs alter prothrombin time by interacting with warfarin levels ( pharmacokinetics )?

95. try its best to collect and build good sentences.

96. Concusion The method can be used in pharmacokinetics of cefathiamidine and provided evidence for clinical application.

97. AIM: To study the pharmacokinetics of leflunomide in Chinese healthy volunteers.

98. The purpose of this paper is to establish a microanalysis method of marine sulfated polysaccharide drug 911 in biological sample—rabbit serum, and to afford prophase study in demic pharmacokinetics.

99. AIM: To study the effect of famotidine on the pharmacokinetics of domperidone.

100. Aim : To study the pharmacokinetics of domestic nifedipine immediate release capsules ( NIRC ) in healthy volunteers.

101. And gave the grey pharmacokinetics model according to blood concentration of compounded Captopril.

102. The pharmacology, pharmacokinetics, clinical uses and side Affects of ibutilide, a new antiarrhythmic drug, were reviewed.

103. OBJECTIVE:To study the pharmacokinetics of lidocaine via epidural injection in patients with mild hepatic dysfunction.